Under the terms of the agreement announced in September, Medtronic will pay approximately $816 million in cash for the acquisition. Kanghui will continue to be led by its current management team under Libo Yang.
More Articles on Orthopedic Devices:
NeuroMetrix Signs Distribution Agreement for Pain Management Device
